GO:0044770 cell cycle phase transition: Regulation, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0044770 cell cycle phase transition describes the commitment step by which a cell enters the next cell cycle phase, a decision point controlled by transcription, phase separation, and checkpoint signaling.
• The G1/S transition is driven by E2F-dependent transcription and CDK2 activity, while the G2/M transition depends on CDK1-CCNB1 and chromatin phase transitions.
• Phase separation of chromatin and regulatory proteins contributes to the physical reorganization required for mitotic entry and chromosome segregation.
• Cell cycle phase transitions are heritable and can be modeled as localization phase transitions in growing populations.
• Dysregulation of phase transition control is linked to cancer, developmental disorders, and infertility, making these steps key therapeutic targets.
• CRISPR knockout, point mutation, knock-in, and overexpression models enable causal testing of genes controlling phase transitions.
Description
The cell cycle is a tightly ordered series of events that ensures faithful duplication and segregation of the genome. GO:0044770 cell cycle phase transition is the biological process by which a cell commits to entering the next cell cycle phase, representing the irreversible decision points that separate G1, S, G2, and M phases. These transitions are not passive consequences of growth but active, regulated commitments that integrate transcriptional programs, checkpoint signaling, and physical reorganization of chromatin. Understanding how cells commit to phase transitions is central to cancer biology, developmental biology, and regenerative medicine, because loss of proper transition control leads to uncontrolled proliferation or cell cycle arrest. Recent work has shown that phase separation phenomena contribute to chromatin organization and chromosome behavior during the cell cycle, adding a biophysical layer to classical CDK-cyclin regulation. Moreover, cell cycle heritability and localization phase transitions have been observed in growing populations, suggesting that commitment decisions can be described quantitatively. This article synthesizes authoritative GO annotations and verified literature to provide a research-grade overview of GO:0044770, its molecular players, disease relevance, and experimental strategies for studying it.
cell cycle phase transition At A Glance
| GO ID | GO:0044770 |
|---|---|
| GO term | cell cycle phase transition |
| Ontology | biological_process |
| Synonym | cell cycle transition |
| Major function | Commitment of a cell to enter the next cell cycle phase |
| Related processes | G1/S transition, G2/M transition, checkpoint control |
| Key regulators | CDKs, cyclins, E2F transcription factors, checkpoint kinases |
| Biophysical aspect | Phase separation of chromatin and regulatory proteins |
| Disease relevance | Cancer, developmental disorders, infertility |
What Is GO:0044770?
According to the Gene Ontology, GO:0044770 cell cycle phase transition is defined as the cell cycle process by which a cell commits to entering the next cell cycle phase. In other words, it is the commitment step, not merely the progression through a phase, that marks the transition from one phase to the next. This process includes the regulatory events that make the transition irreversible, such as activation of specific cyclin-dependent kinase complexes and transcriptional programs. The synonym cell cycle transition is often used interchangeably. The term is a biological_process and should be distinguished from phase-specific processes like DNA replication or mitosis; it specifically captures the commitment to enter the next phase.
Why Is cell cycle phase transition Important in Cell Biology?
Cell cycle phase transitions are fundamental to all proliferating cells and are among the most frequently dysregulated processes in human disease. The commitment to enter S phase or mitosis determines whether a cell divides, arrests, or dies, and errors in this decision can lead to genomic instability and tumorigenesis. Because phase transitions integrate growth signals, DNA damage checkpoints, and developmental cues, they are central to understanding how normal tissues maintain homeostasis and how cancer cells escape these controls. Moreover, phase separation mechanisms at these transitions provide new biophysical targets for therapeutic intervention.
• Controls whether cells commit to DNA replication or mitosis, directly impacting proliferation.
• Integrates growth factor signaling with cell cycle machinery to prevent unscheduled division.
• Dysregulation leads to cancer through loss of checkpoint control at G1/S and G2/M.
• Phase separation at chromatin contributes to proper chromosome segregation and prevents mitotic errors.
• Cell cycle phase transitions are heritable and can be modeled quantitatively in populations.
• Oocyte maturation and early embryonic development depend on precise meiotic phase transitions.
• Bacterial cell cycle phase transitions may be regulated by water-clock mechanisms, highlighting evolutionary conservation.
• Understanding these transitions aids in designing targeted therapies that selectively kill dividing cells.
• Phase transition concepts are being applied to cell polarity and asymmetric division.
• Metabolic state influences cell size and phase transition timing in bioprocess settings.
What Happens During cell cycle phase transition?
G1/S transition commitment
In simple terms: The cell decides to copy its DNA.
The G1/S transition is a point of no return where the cell commits to DNA replication. This commitment is driven by the activation of CDK2 in complex with cyclin E, which phosphorylates RB, releasing E2F transcription factors to activate S-phase genes. This transcriptional program includes genes required for DNA synthesis and replication origin firing. The decision is influenced by growth signals, nutrient availability, and DNA damage checkpoints, ensuring that replication only occurs when conditions are favorable.
G2/M transition and mitotic entry
In simple terms: The cell prepares to divide its copied DNA.
The G2/M transition is triggered by the activation of CDK1-cyclin B complexes, which phosphorylate a wide range of substrates to drive mitotic entry. This transition is controlled by checkpoint kinases that prevent premature mitosis in the presence of DNA damage. Recent studies have shown that a mitotic chromatin phase transition prevents perforation by microtubules, highlighting the physical reorganization required for chromosome segregation. Chromatin organization and chromosome behavior during the cell cycle are also regulated through phase separation mechanisms.
Phase separation in cell cycle transitions
In simple terms: Proteins and DNA separate into droplets to organize the cell.
Phase separation is increasingly recognized as a mechanism that organizes the cytoplasm and nucleus during cell cycle transitions. For example, the mitotic chromatin phase transition creates a dense, protective state that prevents microtubule perforation. Similarly, phase separation of regulatory proteins controls chromatin organization and chromosome behavior throughout the cell cycle. In cell polarity, phase separation contributes to asymmetric division and cell fate determination. These biophysical processes add a layer of spatial regulation to the classical CDK-cyclin machinery.
Checkpoint control and irreversibility
In simple terms: The cell double-checks before committing.
Checkpoints ensure that phase transitions are irreversible and occur only when previous steps are complete. The G1/S checkpoint prevents entry into S phase if DNA is damaged, while the G2/M checkpoint blocks mitosis until replication is finished and damage is repaired. These checkpoints involve kinase cascades that inhibit CDK activity. The commitment to a phase transition is thus a tightly regulated decision that integrates multiple signals.
Heritability and population dynamics
In simple terms: Cell cycle timing can be inherited by daughter cells.
Cell cycle phase transitions are heritable traits that can be modeled as localization phase transitions in growing populations. This means that the timing of commitment to a phase can be passed from mother to daughter cells, influencing population growth dynamics. Such quantitative models help predict how cell cycle heterogeneity affects tissue growth and response to therapy. In bacteria, a water-clock model has been proposed to regulate cell cycle phase transitions, suggesting that similar principles may apply across kingdoms.
Key Genes Involved in GO:0044770 cell cycle phase transition
The following genes and proteins are central to the regulation and execution of cell cycle phase transitions, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CDK1 | Catalytic subunit of M-phase promoting factor; drives G2/M transition | Target for mitotic inhibitors; knockout causes G2 arrest |
| CDK2 | Controls G1/S transition and S phase progression | Key target in cancer; knockout blocks DNA replication |
| CCNB1 | Regulatory subunit of CDK1; required for mitosis | Overexpression linked to cancer; knockout prevents mitotic entry |
| CCNE1 | Regulatory subunit of CDK2; drives G1/S transition | Amplified in cancers; knockout reduces proliferation |
| RB1 | Tumor suppressor; gates G1/S transition by binding E2F | Loss causes uncontrolled G1/S transition in cancer |
| E2F1 | Transcription factor activating S-phase genes | Overexpression promotes proliferation; knockout impairs G1/S |
| TP53 | Checkpoint regulator; induces cell cycle arrest upon DNA damage | Mutations allow bypass of G1/S checkpoint |
| CDKN1A | p21; inhibits CDK2 and CDK1, enforcing checkpoints | Knockout leads to loss of DNA damage-induced arrest |
| CDKN2A | p16; inhibits CDK4/6, preventing G1/S transition | Deletion common in cancer; knockout increases proliferation |
| CCND1 | Cyclin D; activates CDK4/6 to phosphorylate RB | Overexpressed in many cancers; knockout reduces G1/S |
| CDK4 | Partners with cyclin D to initiate G1/S transition | Target of CDK4/6 inhibitors; knockout causes G1 arrest |
| CDK6 | Similar to CDK4; promotes G1/S transition | Inhibitor target; knockout affects cell cycle entry |
| AURKA | Regulates mitotic entry and spindle assembly | Overexpressed in cancer; knockout causes mitotic defects |
| PLK1 | Controls mitotic entry and progression | Inhibitor target; knockout leads to G2/M arrest |
| BUB1 | Spindle assembly checkpoint kinase | Knockout causes chromosome missegregation |
| MAD2L1 | Spindle checkpoint component | Knockdown bypasses mitotic checkpoint |
| WEE1 | Kinase that inhibits CDK1 to prevent premature mitosis | Inhibitor target; knockout causes premature mitotic entry |
| CDC25C | Phosphatase that activates CDK1 at G2/M | Overexpression accelerates mitosis; knockout delays entry |
How Is cell cycle phase transition Regulated?
Cell cycle phase transitions are regulated by a network of cyclin-dependent kinases, checkpoint kinases, and phosphatases. CDK activity is controlled by cyclin binding, phosphorylation by WEE1, and dephosphorylation by CDC25 phosphatases. Transcriptional regulation by E2F and RB family proteins governs the G1/S transition, while mitotic entry is controlled by the balance between WEE1 and CDC25C. Phase separation of regulatory proteins and chromatin also contributes to the spatial organization of these transitions. Additionally, metabolic state and cell size influence the timing of phase transitions, as observed in bioprocess studies.
cell cycle phase transition and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TP53 | Li-Fraumeni syndrome, many cancers | Knockout in cancer cell lines to study checkpoint bypass |
| RB1 | Retinoblastoma, osteosarcoma | Knockout in retinal or osteosarcoma models |
| CDKN2A | Melanoma, pancreatic cancer | Knockout in melanocytes to study G1/S transition |
| CCND1 | Breast cancer, lymphoma | Overexpression in mammary epithelial cells |
| CCNE1 | Ovarian cancer, breast cancer | Overexpression in fallopian tube models |
Cancer
Dysregulation of cell cycle phase transitions is a hallmark of cancer. Mutations in TP53, RB1, and CDKN2A allow cells to bypass G1/S and G2/M checkpoints, leading to uncontrolled proliferation. Overexpression of cyclins and CDKs, such as CCND1 and CDK4, accelerates G1/S transition and is common in many tumors. Targeting these transitions with CDK inhibitors has become a major therapeutic strategy.
Developmental disorders
Proper control of cell cycle phase transitions is essential for normal development. Mutations in genes regulating these transitions can cause developmental disorders characterized by growth retardation or tissue-specific defects. For example, loss of checkpoint control can lead to improper differentiation and organ malformation.
Infertility and reproductive biology
Meiotic phase transitions are critical for oocyte maturation and fertility. Oocyte vitrification, a technique for fertility preservation, relies on understanding these transitions to maintain oocyte viability. Disruptions in meiotic phase transitions can lead to aneuploidy and infertility.
Biotechnological and metabolic implications
In bioprocessing, cell cycle phase transitions affect cell size and productivity. Metabolic characterization of CHO cell size increase during fed-batch cultures has shown that phase transitions influence recombinant protein production. Understanding these transitions can optimize biomanufacturing processes.
From cell cycle phase transition-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of CDK2 block G1/S transition? | CDK2 knockout cell line |
| Does a point mutation in CDK1 affect mitotic entry? | CDK1 point-mutation knock-in |
| Does overexpression of CCND1 accelerate G1/S? | CCND1 overexpression stable line |
| Where does E2F1 localize during phase transition? | E2F1 tagged knock-in |
| Does phase separation of chromatin require specific proteins? | Knockout of phase-separating proteins |
| How does TP53 mutation affect checkpoint? | TP53 point-mutation knock-in |
How to Study the cell cycle phase transition Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Identify E2F targets at G1/S |
| Phosphoproteomics | Phosphorylation of CDK substrates | Map signaling at G2/M |
| Live-cell imaging | Protein localization and dynamics | Visualize phase separation |
| FRAP | Molecular mobility in condensates | Quantify phase separation |
| Flow cytometry | DNA content and cell cycle phase | Measure G1/S and G2/M transitions |
| Western blot | Protein levels and phosphorylation | Check CDK activation |
| CRISPR screening | Gene essentiality for phase transitions | Identify novel regulators |
| Single-cell sequencing | Heterogeneity in phase transition timing | Study population dynamics |
Transcriptomics and RNA-seq
RNA sequencing can measure global changes in gene expression as cells commit to phase transitions. This is particularly useful for identifying E2F target genes activated at G1/S. Time-course RNA-seq after synchronization can reveal waves of transcription associated with each transition.
Proteomics and phosphoproteomics
Mass spectrometry-based proteomics can quantify CDK substrate phosphorylation and protein abundance changes during phase transitions. This helps identify the signaling events that drive commitment. Phosphoproteomics is especially powerful for mapping CDK1 and CDK2 substrates.
Imaging and phase separation assays
Live-cell imaging with fluorescently tagged proteins can visualize phase separation events during cell cycle transitions. For example, chromatin phase transitions can be observed using DNA dyes and tagged histone proteins. Fluorescence recovery after photobleaching (FRAP) can measure dynamics of phase-separated condensates.
Flow cytometry and cell cycle analysis
Flow cytometry with DNA stains and thymidine analogs measures DNA content and S-phase entry, allowing quantification of G1/S and G2/M transitions. Combined with phospho-specific antibodies, it can assess checkpoint activation.
How CRISPR Can Be Used to Study GO:0044770 cell cycle phase transition
Knockout
CRISPR knockout is used to delete genes such as CDK1, CDK2, or CCND1 to determine their requirement for specific phase transitions. For example, CDK2 knockout blocks G1/S transition, while CDK1 knockout causes G2 arrest. Knockout models are essential for validating gene function in cell cycle control.
Point Mutation
Point mutations can be introduced to mimic disease-associated variants or to study phosphorylation sites. For instance, a point mutation in CDK1 that prevents inhibitory phosphorylation can cause premature mitotic entry. Such models help dissect the precise molecular mechanisms of phase transition regulation.
Knock-in
Knock-in of tagged proteins, such as GFP-tagged E2F1 or histone H2B, allows real-time visualization of phase transition dynamics. This is particularly useful for studying phase separation and chromatin reorganization. Knock-in models also enable endogenous promoter-driven expression studies.
Overexpression
Overexpression of cyclins or CDKs, such as CCND1 or CCNE1, can drive cells through phase transitions more rapidly and is used to model oncogenic proliferation. Overexpression models help identify the consequences of elevated CDK activity.
How EDITGENE Supports cell cycle phase transition Research
Researchers studying cell cycle phase transition-related genes often need to determine whether a candidate gene is causally involved in the commitment to enter the next cell cycle phase. This requires precise genetic manipulation, such as knockout, point mutation, knock-in, or overexpression, followed by functional assays. EDITGENE provides end-to-end CRISPR services to accelerate these studies.
Contact EDITGENE today to design your custom CRISPR model for cell cycle phase transition research.
Frequently Asked Questions About cell cycle phase transition
What is GO:0044770 cell cycle phase transition?
GO:0044770 is a Gene Ontology biological process term defined as the cell cycle process by which a cell commits to entering the next cell cycle phase.
What genes are involved in cell cycle phase transition?
Key genes include CDK1, CDK2, CCNB1, CCNE1, RB1, E2F1, TP53, and CDKN1A, among others.
How is the G1/S transition regulated?
The G1/S transition is regulated by CDK2-cyclin E complexes that phosphorylate RB, releasing E2F to activate S-phase genes.
What is the role of phase separation in cell cycle transitions?
Phase separation organizes chromatin and regulatory proteins during transitions, such as the mitotic chromatin phase transition that prevents microtubule perforation.
Which diseases are linked to cell cycle phase transition defects?
Cancer, developmental disorders, and infertility are linked to defects in phase transition control.
How can CRISPR be used to study cell cycle phase transitions?
CRISPR knockout, point mutation, knock-in, and overexpression can be used to test the function of specific genes in phase transitions.
What methods measure cell cycle phase transitions?
Flow cytometry, RNA-seq, phosphoproteomics, and live-cell imaging are commonly used to measure phase transitions.
Is cell cycle phase transition heritable?
Yes, cell cycle heritability and localization phase transitions have been observed in growing populations.
What is the difference between cell cycle phase transition and cell cycle progression?
Phase transition specifically refers to the commitment step to enter the next phase, while progression encompasses all events within a phase.
Can bacteria have cell cycle phase transitions?
Yes, a hypothesis suggests bacteria live on the edge of phase transitions with a cell cycle regulated by a water-clock.
Conclusion
GO:0044770 cell cycle phase transition is a fundamental biological process that governs the commitment of cells to enter the next cell cycle phase. Its regulation involves a complex interplay of CDKs, cyclins, checkpoint kinases, and emerging biophysical mechanisms such as phase separation. Dysregulation of these transitions is central to cancer and other diseases, making them attractive therapeutic targets. Advances in CRISPR technology and quantitative methods continue to unravel the precise molecular events that control phase transitions, offering new opportunities for research and drug discovery.
References
- 1. Bertoli C et al.. 2013. Control of cell cycle transcription during G1 and S phases.. Nat Rev Mol Cell Biol 14(8):518-28 PMID: 23877564
- 2. Wei H et al.. 2021. Phase Separation in Cell Polarity.. Biochemistry 60(36):2677-2684 PMID: 34379397
- 3. Nozoe T et al.. 2020. Cell Cycle Heritability and Localization Phase Transition in Growing Populations.. Phys Rev Lett 125(26):268103 PMID: 33449732
- 4. Schneider MWG et al.. 2022. A mitotic chromatin phase transition prevents perforation by microtubules.. Nature 609(7925):183-190 PMID: 35922507
- 5. Pan X et al.. 2017. Metabolic characterization of a CHO cell size increase phase in fed-batch cultures.. Appl Microbiol Biotechnol 101(22):8101-8113 PMID: 28951949
- 6. Cobo A et al.. 2016. Oocyte vitrification as an efficient option for elective fertility preservation.. Fertil Steril 105(3):755-764.e8 PMID: 26688429
- 7. Li J et al.. 2021. Control of Chromatin Organization and Chromosome Behavior during the Cell Cycle through Phase Separation.. Int J Mol Sci 22(22) PMID: 34830152
- 8. Norris V. 2024. Hypothesis: bacteria live on the edge of phase transitions with a cell cycle regulated by a water-clock.. Theory Biosci 143(4):253-277 PMID: 39505803
